The healthcare sector has begun grappling with a repeat challenge this fall and winter: the simultaneous surge of three significant respiratory diseases—flu, respiratory syncytial virus (RSV), and COVID-19 among both children and adults. When these diseases collide, they constitute what experts have termed a “tripledemic,” which poses a significant strain on the nation’s already burdened healthcare providers and institutions.
